| P50 | author | Mallar Chakravarty | Q87606791 |
| | Christine L Tardif | Q89371479 |
| P2093 | author name string | John Breitner | |
| | Pedro Rosa-Neto | |
| | Judes Poirier | |
| | Robert S C Amaral | |
| | Gabriel A Devenyi | |
| | PREVENT-AD Research Group | |
| | Sandra Pelleieux | |
| P2860 | cites work | Alzheimer's disease as homeostatic responses to age-related myelin breakdown | Q22251261 |
| | Apolipoprotein E and Alzheimer disease | Q24563061 |
| | Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 |
| | The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods | Q24647259 |
| | Suspected non-Alzheimer disease pathophysiology--concept and controversy | Q26771270 |
| | Fractional anisotropy of the fornix and hippocampal atrophy in Alzheimer's disease | Q26827268 |
| | Neuropathological stageing of Alzheimer-related changes | Q27860862 |
| | CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease | Q28728773 |
| | Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 |
| | Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers | Q29620245 |
| | N4ITK: improved N3 bias correction | Q30432754 |
| | Rapid three-dimensional T1-weighted MR imaging with the MP-RAGE sequence | Q30444626 |
| | Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. | Q30908254 |
| | Mapping pathological changes in brain structure by combining T1- and T2-weighted MR imaging data | Q30976200 |
| | Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease | Q30989785 |
| | Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease | Q31142230 |
| | Hippocampal subfields at ultra high field MRI: An overview of segmentation and measurement methods | Q31161237 |
| | Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration | Q33581412 |
| | APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging | Q33695738 |
| | Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation. | Q33741411 |
| | Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies | Q33771165 |
| | White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. | Q33864697 |
| | An optimized blockwise nonlocal means denoising filter for 3-D magnetic resonance images | Q33896952 |
| | Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease | Q33917722 |
| | BEaST: brain extraction based on nonlocal segmentation technique | Q34030054 |
| | Performing label-fusion-based segmentation using multiple automatically generated templates | Q34275639 |
| | Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment | Q34407612 |
| | The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity | Q34482688 |
| | PART and SNAP. | Q34507153 |
| | Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment | Q34630119 |
| | Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain | Q34656983 |
| | Amyloid burden in cognitively normal elderly is associated with preferential hippocampal subfield volume loss | Q35152147 |
| | Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates | Q35160595 |
| | Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. | Q35196845 |
| | Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan | Q35229601 |
| | Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol. | Q35286739 |
| | Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer type | Q35842864 |
| | Sub-Regional Hippocampal Injury is Associated with Fornix Degeneration in Alzheimer's Disease | Q35882069 |
| | Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults | Q35985990 |
| | Use of T1-weighted/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain. | Q36186550 |
| | 7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature. | Q36297447 |
| | An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease | Q36650399 |
| | White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration | Q36736127 |
| | Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space | Q36744339 |
| | The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals | Q37090083 |
| | Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people | Q37129672 |
| | Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects | Q37181281 |
| | Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia. | Q37217094 |
| | Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. | Q37220632 |
| | Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid | Q37237399 |
| | Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity | Q37291586 |
| | Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease | Q37472360 |
| | Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition | Q37486266 |
| | Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease. | Q37603879 |
| | Neuroimaging biomarkers in Alzheimer's disease and other dementias | Q38717107 |
| | Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry | Q38906604 |
| | Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls | Q39028745 |
| | Intracortical myelin links with performance variability across the human lifespan: results from T1- and T2-weighted MRI myelin mapping and diffusion tensor imaging | Q39310979 |
| | Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology | Q39466317 |
| | Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease | Q39929112 |
| | Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study | Q40349700 |
| | White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. | Q41233743 |
| | Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy | Q42330310 |
| | Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia | Q43197308 |
| | Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain | Q43585412 |
| | Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease | Q43593305 |
| | Larger temporal volume in elderly with high versus low beta-amyloid deposition | Q43965311 |
| | A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals? | Q46189231 |
| | Manual segmentation of the fornix, fimbria, and alveus on high-resolution 3T MRI: Application via fully-automated mapping of the human memory circuit white and grey matter in healthy and pathological aging | Q47907320 |
| | A novel in vivo atlas of human hippocampal subfields using high-resolution 3 T magnetic resonance imaging | Q48160392 |
| | Hippocampal (subfield) volume and shape in relation to cognitive performance across the adult lifespan | Q48185314 |
| | Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons | Q48351621 |
| | A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. | Q48367859 |
| | Effects of age and Alzheimer's disease on hippocampal subfields: comparison between manual and FreeSurfer volumetry | Q48534902 |
| | Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics | Q48842795 |
| | CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study | Q50413832 |
| | Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype | Q50438864 |
| | Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas. | Q51011713 |
| | Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease. | Q52863124 |
| | Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. | Q53236394 |
| | Apolipoprotein E polymorphism and Alzheimer's disease. | Q53316388 |
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | cerebrospinal fluid | Q54196 |
| | biomarker | Q864574 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 971-984 | |
| P577 | publication date | 2017-11-21 | |
| P1433 | published in | Human Brain Mapping | Q5936947 |
| P1476 | title | Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease | |
| P478 | volume | 39 | |